Sheridan Capital

Canaccord Genuity Advises Sheridan Capital on its Investment in Healthcare Advisory Firm ADVI Health

Private equity firm takes ownership stake in growing consultancy dedicated to solving complicated problems in healthcare 
​​​​​​​
Canaccord Genuity is pleased to announce it has advised Sheridan Capital on its investment in healthcare advisory firm ADVI Health. Sheridan invested alongside ADVI’s senior leaders, who retained a meaningful ownership stake in the business and who will remain active in the leadership and operations of the company. Together, the company’s executive team and Sheridan aim to accelerate, strengthen, and extend ADVI’s position as an established market access, commercialization, and policy firm through the expansion of its solutions and product offerings.

ADVI Health solves complicated problems in healthcare with data-informed commercialization, market access, and policy expertise. Comprised of a seasoned group of industry experts from the policy, payer, and life sciences sectors, ADVI provides strategic support to health and science innovators around the world. It guides clients from diligence and discovery through commercialization, proactively identifying opportunities to improve access and reimbursement and accelerate time to revenue and growth. ADVI’s real-time Strategic Analytics and Value Economics (SAVEs) data set spans multiple payers (100% Medicaid, Medicare FFS, and Medicare Advantage) and covers more than 200 million lives, providing clients with invaluable competitive intelligence.

For the last decade, ADVI has provided invaluable guidance, insight, and advice to its customers tackling complex and critical commercialization initiatives. Founded in 2013, with roots back to 2008, ADVI is committed to providing clients with the advice and vision necessary to translate the value of client products and services into the language and currency of payers, both public and private. Its veteran team of collaborative, creative trailblazers have become the go-to resource for advancing and addressing clinical, economic, policy, and operational opportunities and challenges faced by life science and healthcare leaders. The firm combines the advice, action, and tools of traditional consulting with the rigor and vision of corporate strategy. ADVI’s real-time intelligence, unique datasets and targeted advocacy are advancing innovation for cell and gene, vaccine, rare and ultra-rare diseases, and oncology therapies; digital therapeutics; AI advances; complex diagnostics; and MedTech. ADVI is headquartered in Washington, DC.

ADVI is excited to partner with the team at Sheridan. The company’s exclusive focus on healthcare and deep investment expertise will allow the firm to invest further in its team and expand solutions, products, and reach more quickly, so that ADVI can collaborate in new ways with medical innovators and entrepreneurs, life science and digital therapy manufacturers, and providers and advocates around the world.

Sheridan is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the US and Canada. Sheridan partners with companies in the verticals of providers and provider services, healthcare IT and outsourced services, and consumer health and medical products, bringing strategic resources to accelerate growth, build enduring value, and achieve strong results.

Canaccord Genuity, with a team led by Tom O’Connor, served as the financial advisor to Sheridan Capital.